Protective Effects of Coumestrol on Metabolic Dysfunction and Its Estrogen Receptor-Mediated Action in Ovariectomized Mice

Coumestrol, a phytoestrogen compound found in various plants, has been shown to act as a potent estrogen receptor (ER) agonist, with a higher binding affinity for ERβ than for ERα. However, there is currently limited information regarding its beneficial effects in postmenopausal disorders and its ER...

Full description

Bibliographic Details
Main Authors: Song Park, Kyu-Sang Sim, Wan Heo, Jun-Ho Kim
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Nutrients
Subjects:
Online Access:https://www.mdpi.com/2072-6643/15/4/954
_version_ 1797618902551756800
author Song Park
Kyu-Sang Sim
Wan Heo
Jun-Ho Kim
author_facet Song Park
Kyu-Sang Sim
Wan Heo
Jun-Ho Kim
author_sort Song Park
collection DOAJ
description Coumestrol, a phytoestrogen compound found in various plants, has been shown to act as a potent estrogen receptor (ER) agonist, with a higher binding affinity for ERβ than for ERα. However, there is currently limited information regarding its beneficial effects in postmenopausal disorders and its ER-mediated mechanisms. Herein, we investigated the effects of coumestrol (subcutaneous or oral treatment) on metabolic dysfunction in ovariectomized (OVX) mice fed a high-fat diet, in comparison with the effects of 17β-estradiol (E2) replacement. Coumestrol was administered daily at a dose of 5 mg/kg for 10 weeks. Coumestrol treatment through the subcutaneous route stimulated uterine growth in OVX mice at a level lower than that of E2. E2 and coumestrol prevented body fat accumulation, adipocyte hypertrophy, and hepatic steatosis, and enhanced voluntary physical activity. Coumestrol showed estrogen-mimetic effects in the regulation of the protein expressions involved in browning of white fat and insulin signaling, including increased hepatic expression of fibroblast growth factor 21. Importantly, the metabolic effects of coumestrol (oral administration at 10 mg/kg for 7 weeks) were mostly abolished following co-treatment with an ERβ-selective antagonist but not with an ERα-selective antagonist, indicating that the metabolic actions of coumestrol in OVX mice are primarily mediated by ERβ. These findings provide important insights into the beneficial effects of coumestrol as a phytoestrogen supplement for the prevention and treatment of postmenopausal symptoms.
first_indexed 2024-03-11T08:19:10Z
format Article
id doaj.art-b665d2e77e0b4130a615ed7a1ba5abb3
institution Directory Open Access Journal
issn 2072-6643
language English
last_indexed 2024-03-11T08:19:10Z
publishDate 2023-02-01
publisher MDPI AG
record_format Article
series Nutrients
spelling doaj.art-b665d2e77e0b4130a615ed7a1ba5abb32023-11-16T22:31:12ZengMDPI AGNutrients2072-66432023-02-0115495410.3390/nu15040954Protective Effects of Coumestrol on Metabolic Dysfunction and Its Estrogen Receptor-Mediated Action in Ovariectomized MiceSong Park0Kyu-Sang Sim1Wan Heo2Jun-Ho Kim3Department of Food Science and Biotechnology, Andong National University, Andong 36729, Republic of KoreaBiomaterials Research Institute, Kyochon F&B, Andong 36618, Republic of KoreaDepartment of Food Science and Engineering, Seowon University, Cheongju 28674, Republic of KoreaDepartment of Food Science and Biotechnology, Andong National University, Andong 36729, Republic of KoreaCoumestrol, a phytoestrogen compound found in various plants, has been shown to act as a potent estrogen receptor (ER) agonist, with a higher binding affinity for ERβ than for ERα. However, there is currently limited information regarding its beneficial effects in postmenopausal disorders and its ER-mediated mechanisms. Herein, we investigated the effects of coumestrol (subcutaneous or oral treatment) on metabolic dysfunction in ovariectomized (OVX) mice fed a high-fat diet, in comparison with the effects of 17β-estradiol (E2) replacement. Coumestrol was administered daily at a dose of 5 mg/kg for 10 weeks. Coumestrol treatment through the subcutaneous route stimulated uterine growth in OVX mice at a level lower than that of E2. E2 and coumestrol prevented body fat accumulation, adipocyte hypertrophy, and hepatic steatosis, and enhanced voluntary physical activity. Coumestrol showed estrogen-mimetic effects in the regulation of the protein expressions involved in browning of white fat and insulin signaling, including increased hepatic expression of fibroblast growth factor 21. Importantly, the metabolic effects of coumestrol (oral administration at 10 mg/kg for 7 weeks) were mostly abolished following co-treatment with an ERβ-selective antagonist but not with an ERα-selective antagonist, indicating that the metabolic actions of coumestrol in OVX mice are primarily mediated by ERβ. These findings provide important insights into the beneficial effects of coumestrol as a phytoestrogen supplement for the prevention and treatment of postmenopausal symptoms.https://www.mdpi.com/2072-6643/15/4/954coumestrolestrogen receptormetabolic dysfunctionpostmenopausal disordersovariectomized mouse
spellingShingle Song Park
Kyu-Sang Sim
Wan Heo
Jun-Ho Kim
Protective Effects of Coumestrol on Metabolic Dysfunction and Its Estrogen Receptor-Mediated Action in Ovariectomized Mice
Nutrients
coumestrol
estrogen receptor
metabolic dysfunction
postmenopausal disorders
ovariectomized mouse
title Protective Effects of Coumestrol on Metabolic Dysfunction and Its Estrogen Receptor-Mediated Action in Ovariectomized Mice
title_full Protective Effects of Coumestrol on Metabolic Dysfunction and Its Estrogen Receptor-Mediated Action in Ovariectomized Mice
title_fullStr Protective Effects of Coumestrol on Metabolic Dysfunction and Its Estrogen Receptor-Mediated Action in Ovariectomized Mice
title_full_unstemmed Protective Effects of Coumestrol on Metabolic Dysfunction and Its Estrogen Receptor-Mediated Action in Ovariectomized Mice
title_short Protective Effects of Coumestrol on Metabolic Dysfunction and Its Estrogen Receptor-Mediated Action in Ovariectomized Mice
title_sort protective effects of coumestrol on metabolic dysfunction and its estrogen receptor mediated action in ovariectomized mice
topic coumestrol
estrogen receptor
metabolic dysfunction
postmenopausal disorders
ovariectomized mouse
url https://www.mdpi.com/2072-6643/15/4/954
work_keys_str_mv AT songpark protectiveeffectsofcoumestrolonmetabolicdysfunctionanditsestrogenreceptormediatedactioninovariectomizedmice
AT kyusangsim protectiveeffectsofcoumestrolonmetabolicdysfunctionanditsestrogenreceptormediatedactioninovariectomizedmice
AT wanheo protectiveeffectsofcoumestrolonmetabolicdysfunctionanditsestrogenreceptormediatedactioninovariectomizedmice
AT junhokim protectiveeffectsofcoumestrolonmetabolicdysfunctionanditsestrogenreceptormediatedactioninovariectomizedmice